|
1
|
Yi J, Zheng Y, Miao C, Tang J and Zhu B:
Desflurane preconditioning induces oscillation of NF-κB in human
umbilical vein endothelial cells. PLoS One. 8:e665762013.
View Article : Google Scholar
|
|
2
|
Ding WG, Zhou HC, Cui XG, Li WZ, Guo YP,
Zhang B and Liu W: Anti-apoptotic effect of morphine-induced
delayed preconditioning on pulmonary artery endothelial cells with
anoxia/reoxygenation injury. Chin Med J (Engl). 121:1313–1318.
2008.
|
|
3
|
Yu EZ, Li YY, Liu XH, Kagan E and McCarron
RM: Antiapoptotic action of hypoxia-inducible factor-1 alpha in
human endothelial cells. Lab Invest. 84:553–561. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hu Y, Li L, Yin W, Shen L, You B and Gao
H: Protective effect of proanthocyanidins on anoxia-reoxygenation
injury of myocardial cells mediated by the PI3K/Akt/GSK-3β pathway
and mitochondrial ATP-sensitive potassium channel. Mol Med Rep.
10:2051–2058. 2014.PubMed/NCBI
|
|
5
|
Rui T and Tang Q: IL-33 attenuates
anoxia/reoxygenation-induced cardiomyocyte apoptosis by inhibition
of PKCβ/JNK pathway. PLoS One. 8:e560892013. View Article : Google Scholar
|
|
6
|
Zhang C, Lin G, Wan W, Li X, Zeng B, Yang
B and Huang C: Resveratrol, a polyphenol phytoalexin, protects
cardiomyocytes against anoxia/reoxygenation injury via the
TLR4/NF-κB signaling pathway. Int J Mol Med. 29:557–563.
2012.PubMed/NCBI
|
|
7
|
Li WJ, Nie SP, Chen Y, Xie MY, He M, Yu Q
and Yan Y: Ganoderma atrum polysaccharide protects cardiomyocytes
against anoxia/reoxygenation-induced oxidative stress by
mitochondrial pathway. J Cell Biochem. 110:191–200. 2010.PubMed/NCBI
|
|
8
|
Zaugg M, Lucchinetti E, Garcia C, Pasch T,
Spahn DR and Schaub MC: Anaesthetics and cardiac preconditioning.
Part II. Clinical implications. Br J Anaesth. 91:566–576. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zaugg M, Lucchinetti E, Uecker M, Pasch T
and Schaub MC: Anaesthetics and cardiac preconditioning. Part I.
Signalling and cytoprotective mechanisms. Br J Anaesth. 91:551–565.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Piriou V, Chiari P, Lhuillier F, Bastien
O, Loufoua J, Raisky O, David JS, Ovize M and Lehot JJ:
Pharmacological preconditioning: comparison of desflurane,
sevoflurane, isoflurane and halothane in rabbit myocardium. Br J
Anaesth. 89:486–491. 2002.PubMed/NCBI
|
|
11
|
Haelewyn B, Zhu L, Hanouz JL, Persehaye E,
Roussel S, Ducouret P and Gérard JL: Cardioprotective effects of
desflurane: effect of timing and duration of administration in rat
myocardium. Br J Anaesth. 92:552–557. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Suleiman MS, Zacharowski K and Angelini
GD: Inflammatory response and cardioprotection during open-heart
surgery: the importance of anaesthetics. Br J Pharmacol. 153:21–33.
2008. View Article : Google Scholar
|
|
13
|
Wang H, Lu S, Yu Q, Liang W, Gao H, Li P,
Gan Y, Chen J and Gao Y: Sevoflurane preconditioning confers
neuroprotection via anti-inflammatory effects. Front Biosci (Elite
Ed). 3:604–615. 2011. View
Article : Google Scholar
|
|
14
|
Boost KA, Flondor M, Hofstetter C,
Platacis I, Stegewerth K, Hoegl S, Nguyen T, Muhl H and Zwissler B:
The beta-adrenoceptor antagonist propranolol counteracts
anti-inflammatory effects of isoflurane in rat endotoxemia. Acta
Anaesthesiol Scand. 51:900–908. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liang Y, Li Z, Mo N, Li M, Zhuang Z, Wang
J, Wang Y and Guo X: Isoflurane preconditioning ameliorates renal
ischemia-reperfusion injury through antiinflammatory and
antiapoptotic actions in rats. Biol Pharm Bull. 37:1599–1605. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bedirli N, Demirtas CY, Akkaya T, Salman
B, Alper M, Bedirli A and Pasaoglu H: Volatile anesthetic
preconditioning attenuated sepsis induced lung inflammation. J Surg
Res. 178:e17–e23. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Biao Z, Zhanggang X, Hao J, Changhong M
and Jing C: The in vitro effect of desflurane preconditioning on
endothelial adhesion molecules and mRNA expression. Anesth Analg.
100:1007–1013. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li Y, Zhang X, Zhu B and Xue Z: Desflurane
preconditioning inhibits endothelial nuclear factor-kappa-B
activation by targeting the proximal end of tumor necrosis
factor-alpha signaling. Anesth Analg. 106:1473–1479. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kopp EB and Ghosh S: NF-kappaB and rel
proteins in innate immunity. Adv Immunol. 58:1–27. 1995. View Article : Google Scholar
|
|
20
|
Tsung A, Hoffman RA, Izuishi K, Critchlow
ND, Nakao A, Chan MH, Lotze MT, Geller DA and Billiar TR: Hepatic
ischemia/reperfusion injury involves functional TLR4 signaling in
nonparenchymal cells. J Immunol. 175:7661–7668. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Donnahoo KK, Meldrum DR, Shenkar R, Chung
CS, Abraham E and Harken AH: Early renal ischemia, with or without
reperfusion, activates NFkappaB and increases TNF-alpha bioactivity
in the kidney. J Urol. 163:1328–1332. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Baeuerle PA and Baltimore D: NF-kappaB:
ten years after. Cell. 87:13–20. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kokura S, Wolf RE, Yoshikawa T, Granger DN
and Aw TY: T-lymphocyte-derived tumor necrosis factor exacerbates
anoxiareoxygenation-induced neutrophil-endothelial cell adhesion.
Circ Res. 86:205–213. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Karakurum M, Shreeniwas R, Chen J, Pinsky
D, Yan SD, Anderson M, Sunouchi K, Major J, Hamilton T and Kuwabara
K: Hypoxic induction of interleukin-8 gene expression in human
endothelial cells. J Clin Invest. 93:1564–1570. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Loop T, Dovi-Akue D, Frick M, Roesslein M,
Egger L, Humar M, Hoetzel A, Schmidt R, Borner C, Pahl HL, et al:
Volatile anesthetics induce caspase-dependent,
mitochondria-mediated apoptosis in human T lymphocytes in vitro.
Anesthesiology. 102:1147–1157. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Coope HJ, Atkinson PG, Huhse B, Belich M,
Janzen J, Holman MJ, Klaus GG, Johnston LH and Ley SC: CD40
regulates the processing of NF-kappaB2 p100 to p52. EMBO J.
21:5375–5385. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ganeff C, Remouchamps C, Boutaffala L,
Benezech C, Galopin G, Vandepaer S, Bouillenne F, Ormenese S,
Chariot A, Schneider P, et al: Induction of the alternative NF-κB
pathway by lymphotoxin αβ (LTαβ) relies on internalization of LTβ
receptor. Mol Cell Biol. 31:4319–4334. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Claudio E, Brown K, Park S, Wang H and
Siebenlist U: BAFF-induced NEMO-independent processing of NF-kappa
B2 in maturing B cells. Nat Immunol. 3:958–965. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Dejardin E: The alternative NF-kappaB
pathway from biochemistry to biology: pitfalls and promises
forfuture drug development. Biochem Pharmacol. 72:1161–1179. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zaki MH, Boyd KL, Vogel P, Kastan MB,
Lamkanfi M and Kanneganti TD: The NLRP3 inflammasome protects
against loss of epithelial integrity and mortality during
experimental colitis. Immunity. 32:379–391. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Allen IC, TeKippe EM, Woodford RM, Uronis
JM, Holl EK, Rogers AB, Herfarth HH, Jobin C and Ting JP: The NLRP3
inflammasome functions as a negative regulator of tumorigenesis
during colitis-associated cancer. J Exp Med. 207:1045–1056. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hu B, Elinav E, Huber S, Strowig T, Hao L,
Hafemann A, Jin C, Wunderlich C, Wunderlich T, Eisenbarth SC and
Flavell RA: Microbiota-induced activation of epithelial IL-6
signaling links inflammasome-driven inflammation with transmissible
cancer. Proc Natl Acad Sci USA. 110:9862–9867. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hu B, Elinav E, Huber S, Booth CJ, Strowig
T, Jin C, Eisenbarth SC and Flavell RA: Inflammation-induced
tumorigenesis in the colon is regulated by caspase-1 and NLRC4.
Proc Natl Acad Sci USA. 107:21635–21640. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chen GY: Role of Nlrp6 and Nlrp12 in the
maintenance of intestinal homeostasis. Eur J Immunol. 44:321–327.
2014. View Article : Google Scholar :
|
|
35
|
Zhang L, Mo J, Swanson KV, Wen H,
Petrucelli A, Gregory SM, Zhang Z, Schneider M, Jiang Y, Fitzgerald
KA, et al: NLRC3, a member of the NLR family of proteins, is a
negative regulator of innate immune signaling induced by the DNA
sensor STING. Immunity. 40:329–341. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Xia X, Cui J, Wang HY, Zhu L, Matsueda S,
Wang Q, Yang X, Hong J, Songyang Z, Chen ZJ and Wang RF: NLRX1
negatively regulates TLR-induced NF-kappaB signaling by targeting
TRAF6 and IKK. Immunity. 34:843–853. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Lich JD, Williams KL, Moore CB, Arthur JC,
Davis BK, Taxman DJ and Ting JP: Monarch-1 suppresses non-canonical
NF-kappaB activation and p52-dependent chemokine expression in
monocytes. Journal of immunology. 178:1256–1260. 2007. View Article : Google Scholar
|
|
38
|
Wang L, Manji GA, Grenier JM, Al-Garawi A,
Merriam S, Lora JM, Geddes BJ, Briskin M, DiStefano PS and Bertin
J: PYPAF7, a novel PYRIN-containing Apaf1-like protein that
regulates activation of NF-kappa B and caspase-1-dependent cytokine
processing. J Biol Chem. 277:29874–29880. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Vladimer GI, Weng D, Paquette SW, Vanaja
SK, Rathinam VA, Aune MH, Conlon JE, Burbage JJ, Proulx MK and Liu
Q: The NLRP12 inflammasome recognizes Yersinia pestis. Immunity.
37:96–107. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Ataide MA, Andrade WA, Zamboni DS, Wang D,
Souza Mdo C, Franklin BS, Elian S, Martins FS, Pereira D, Reed G,
et al: Malaria-induced NLRP12/NLRP3-dependent caspase-1 activation
mediates inflammation and hypersensitivity to bacterial
superinfection. PLoS Pathog. 10:e10038852014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Allen IC, McElvania-TeKippe E, Wilson JE,
Lich JD, Arthur JC, Sullivan JT, Braunstein M and Ting JP:
Characterization of NLRP12 during the in vivo host immune response
to Klebsiella pneumoniae and Mycobacterium tuberculosis. PloS One.
8:e608422013. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Allen IC, Wilson JE, Schneider M, Lich JD,
Roberts RA, Arthur JC, Woodford RM, Davis BK, Uronis JM, Herfarth
HH, et al: NLRP12 suppresses colon inflammation and tumorigenesis
through the negative regulation of noncanonical NF-kappaB
signaling. Immunity. 36:742–754. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Allen IC, Lich JD, Arthur JC, et al:
Characterization of NLRP12 during the development of allergic
airway disease in mice. PloS one. 7:e306122012. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Zaki MH, Vogel P, Malireddi RK,
Body-Malapel M, Anand PK, Bertin J, Green DR, Lamkanfi M and
Kanneganti TD: The NOD-like receptor NLRP12 attenuates colon
inflammation and tumorigenesis. Cancer Cell. 20:649–660. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Pinheiro AS, Eibl C, Ekman-Vural Z,
Schwarzenbacher R and Peti W: The NLRP12 pyrin domain: structure,
dynamics, and functional insights. J Mol Biol. 413:790–803. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Arthur JC, Lich JD, Ye Z, Allen IC, Gris
D, Wilson JE, Schneider M, Roney KE, O'Connor BP and Moore CB:
Cutting edge: NLRP12 controls dendritic and myeloid cell migration
to affect contact hypersensitivity. J Immunol. 185:4515–4519. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Baudin B, Bruneel A, Bosselut N and
Vaubourdolle M: A protocol for isolation and culture of human
umbilical vein endothelial cells. Nat Protoc. 2:481–485. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Takahashi K, Sawasaki Y, Hata J, Mukai K
and Goto T: Spontaneous transformation and immortalization of human
endothelial cells. In Vitro Cell Dev Biol. 26:265–274. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Koyama T, Temma K and Akera T:
Reperfusion-induced contracture develops with a decreasing [Ca2+]i
in single heart cells. Am J Physiol. 261:H1115–H1122.
1991.PubMed/NCBI
|
|
50
|
Mouithys-Mickalad A, Mathy-Hartert M, Du
G, Sluse F, Deby C, Lamy M and Deby-Dupont G: Oxygen consumption
and electron spin resonance studies of free radical production by
alveolar cells exposed to anoxia: inhibiting effects of the
antibiotic ceftazidime. Redox Rep. 7:85–94. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Ichikawa H, Flores S, Kvietys PR, Wolf RE,
Yoshikawa T, Granger DN and Aw TY: Molecular mechanisms of
anoxia/reoxygenation-induced neutrophil adherence to cultured
endothelial cells. Circ Res. 81:922–931. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Cepinskas G1, Lush CW and Kvietys PR:
Anoxia/reoxygenation-induced tolerance with respect to
polymorphonuclear leukocyte adhesion to cultured endothelial cells.
A nuclear factor-kappaB-mediated phenomenon. Circ Res. 84:103–12.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Rupin A, Paysant J, Sansilvestri-Morel P,
Lembrez N, Lacoste JM, Cordi A and Verbeuren TJ: Role of NADPH
oxidase-mediated superoxide production in the regulation of
E-selectin expression by endothelial cells subjected to
anoxia/reoxygenation. Cardiovasc Res. 63:323–30. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Lich JD and Ting JP: Monarch-1/PYPAF7 and
other CATERPILLER (CLR, NOD, NLR) proteins with negative regulatory
functions. Microbes Infect. 9:672–676. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Williams KL, Lich JD, Duncan JA, Reed W,
Rallabhandi P, Moore C, Kurtz S, Coffield VM, Accavitti-Loper MA,
Su L, et al: The CATERPILLER protein monarch-1 is an antagonist of
toll-like receptor-, tumor necrosis factor alpha-, and
Mycobacterium tuberculosis-induced pro-inflammatory signals. J Biol
Chem. 280:39914–39924. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Green DR and Kroemer G: The
pathophysiology of mitochondrial cell death. Science. 305:626–629.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Hennessy EJ, Saeh JC, Sha L, MacIntyre T,
Wang H, Larsen NA, Aquila BM, Ferguson AD, Laing NM and Omer CA:
Discovery of aminopiperidine-based Smac mimetics as IAP
antagonists. Bioorg Med Chem Lett. 22:1690–1694. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Zhang B, Dong Y, Zhang G, Moir RD, Xia W,
Yue Y, Tian M, Culley DJ, Crosby G, Tanzi RE and Xie Z: The
inhalation anesthetic desflurane induces caspase activation and
increases amyloid beta-protein levels under hypoxic conditions. J
Biol Chem. 283:11866–11875. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Mahoney DJ, Cheung HH, Mrad RL, Plenchette
S, Simard C, Enwere E, Arora V, Mak TW, Lacasse EC, Waring J and
Korneluk RG: Both cIAP1 and cIAP2 regulate TNFalpha-mediated
NF-kappaB activation. Proc Natl Acad Sci USA. 105:11778–11783.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Varfolomeev E and Vucic D: (Un)expected
roles of c-IAPs in apoptotic and NF-kappaB signaling pathways. Cell
Cycle. 7:1511–1521. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Vatsyayan J, Qing G, Xiao G and Hu J:
SUMO1 modification of NF-kappaB2/p100 is essential for
stimuli-induced p100 phosphorylation and processing. EMBO Rep.
9:885–890. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Heusch M, Lin L, Geleziunas R and Greene
WC: The generation of nfkb2 p52: mechanism and efficiency.
Oncogene. 18:64–6208. 1999. View Article : Google Scholar
|
|
63
|
Xiao G, Fong A and Sun SC: Induction of
p100 processing by NF-kappaB-inducing kinase involves docking
IkappaB kinase alpha (IKKalpha) to p100 and IKKalpha-mediated
phosphorylation. J Biol Chem. 279:30099–30105. 2004. View Article : Google Scholar : PubMed/NCBI
|
